Friday, May 1, 2026
ISSN 2765-8767
  • Survey
  • Podcast
  • Write for Us
  • My Account
  • Log In
Daily Remedy
  • Home
  • Articles
  • Podcasts
    How NADAC, WAC, and ASP Shape Drug Costs

    How NADAC, WAC, and ASP Shape Drug Costs

    April 20, 2026
    The Hidden Costs Employers Don’t See in Traditional Health Plans

    The Hidden Costs Employers Don’t See in Traditional Health Plans

    March 22, 2026
    The Impact of COVID-19 on Patient Trust

    The Impact of COVID-19 on Patient Trust

    March 3, 2026
    Debunking Myths About GLP-1 Medications

    Debunking Myths About GLP-1 Medications

    February 16, 2026
    The Future of LLMs in Healthcare

    The Future of LLMs in Healthcare

    January 26, 2026
    The Future of Healthcare Consumerism

    The Future of Healthcare Consumerism

    January 22, 2026
  • Surveys

    Surveys

    Public Perception of Peptide Regulation and Compounding Practices

    Public Perception of Peptide Regulation and Compounding Practices

    April 19, 2026
    Understanding of Clinical Evidence in Peptide and Hormone Use

    Understanding of Clinical Evidence in Peptide and Hormone Use

    March 30, 2026

    Survey Results

    Can you tell when your provider does not trust you?

    Can you tell when your provider does not trust you?

    January 18, 2026
    Do you believe national polls on health issues are accurate

    National health polls: trust in healthcare system accuracy?

    May 8, 2024
    Which health policy issues matter the most to Republican voters in the primaries?

    Which health policy issues matter the most to Republican voters in the primaries?

    May 14, 2024
    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    May 7, 2024
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner
No Result
View All Result
  • Home
  • Articles
  • Podcasts
    How NADAC, WAC, and ASP Shape Drug Costs

    How NADAC, WAC, and ASP Shape Drug Costs

    April 20, 2026
    The Hidden Costs Employers Don’t See in Traditional Health Plans

    The Hidden Costs Employers Don’t See in Traditional Health Plans

    March 22, 2026
    The Impact of COVID-19 on Patient Trust

    The Impact of COVID-19 on Patient Trust

    March 3, 2026
    Debunking Myths About GLP-1 Medications

    Debunking Myths About GLP-1 Medications

    February 16, 2026
    The Future of LLMs in Healthcare

    The Future of LLMs in Healthcare

    January 26, 2026
    The Future of Healthcare Consumerism

    The Future of Healthcare Consumerism

    January 22, 2026
  • Surveys

    Surveys

    Public Perception of Peptide Regulation and Compounding Practices

    Public Perception of Peptide Regulation and Compounding Practices

    April 19, 2026
    Understanding of Clinical Evidence in Peptide and Hormone Use

    Understanding of Clinical Evidence in Peptide and Hormone Use

    March 30, 2026

    Survey Results

    Can you tell when your provider does not trust you?

    Can you tell when your provider does not trust you?

    January 18, 2026
    Do you believe national polls on health issues are accurate

    National health polls: trust in healthcare system accuracy?

    May 8, 2024
    Which health policy issues matter the most to Republican voters in the primaries?

    Which health policy issues matter the most to Republican voters in the primaries?

    May 14, 2024
    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    May 7, 2024
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner
No Result
View All Result
Daily Remedy
No Result
View All Result
Home Trends

Another Year, More Overdose Records

The numbers keep rising

Jay K Joshi by Jay K Joshi
May 1, 2024
in Trends
0
Another Year, More Overdose Records

Jakub Zerdzicki

The latest data from the Centers for Disease Control and Prevention (CDC) has revealed that drug overdoses in the United States have reached another grim milestone in 2022. Shockingly, the figures show that nearly 108,000 Americans lost their lives due to drug overdoses during the year. This distressing number highlights the relentless and devastating impact of the drug epidemic that has plagued the nation for the past two decades, urgently calling for remedy healthcare initiatives and reformed healthcare policy.

Tragically, the number of overdose deaths in the United States has been steadily increasing year after year, a disturbing trend that shows no signs of abating. In fact, every year seems to bring a new record, surpassing the previous year’s grim toll. Such a relentless rise has now made this the worst overdose epidemic in the nation’s history, demonstrating a clear failure in healthcare policy.

The magnitude of this crisis cannot be overstated. Behind each statistic is a life cut short, a family shattered, and a community left grappling with grief and loss. The repercussions of these overdose deaths ripple through society, affecting not only the families directly affected but also healthcare systems, law enforcement agencies, and the overall wellbeing of the nation. These tragic outcomes underscore the urgent need for comprehensive healthcare policy reforms and innovative remedy healthcare strategies.

Efforts to combat this epidemic have been ongoing, but it is clear that more needs to be done. Raising awareness, improving access to supportive services, and addressing underlying issues such as mental health and addiction are crucial steps in curbing the devastating impact of drug overdoses. But it is not enough.

We need to change the way we think systematically. The system is at fault – not any one individual, entity, or company. And that is what we fail to understand. We attribute blame to anything that justifies our anger and pain. But redirecting raw emotions is not the way to enact health policy. But that is what we do.

What is worse is that those who know better are in no hurry to fix this – because they are the ones who benefit. The war on drugs has been an unmitigated disaster to American society. Yet we continue to adhere to failed policies as though by trying just a little harder, something might change. But as the famous quip goes: Insanity is doing the same thing over and over again and expecting different results. This reflects a profound misunderstanding in health policy topics and a rejection of modern medical insights.

But those in positions of power know the results will be the same. It is only the assuming public that thinks otherwise. The families with lost loved ones. The communities that were torn apart. Those are the ones who hold on to this false hope that things will turn around.

The policy makers know better. They know the flaws in the system they oversee. Yet they doggedly hold on to the same prohibitionist policies, ignoring modern medical evidence that could guide more effective interventions. When they see prescription opioids decreasing and overdoses increasing, they somehow justify that prescriptions have not decreased enough. And people actually believe it. When they see clinical studies demonstrating the value of harm reduction, they distort the issue to be anything but clinical in nature.

Make no mistake: the Drug Enforcement Agency (DEA) is directly responsible for the rising overdose rates. This agency has perpetuated a culture of fear that has driven out well meaning physicians and community activists from doing what is only sensible for patients with substance use dependency. No matter how loud the voice, the DEAs ears remain deaf.

To extract a word from the quip from above: it is insanity. But that would be giving the DEA too much credit. It is actually malicious intent. The DEA knows its very existence is anathema to clinical principles of harm reduction. The very principles that would curb the mounting overdoses. Rather than acknowledge its failed policies, it chooses self-preservation over the lives of the American public.

The DEA would rather carry on with its false agenda at the cost of American lives. So the next time you see an article about patients not having access to medical care or read about another person overdosing, remember who is responsible.

ShareTweet
Jay K Joshi

Jay K Joshi

Dr. Joshi is the founding editor of Daily Remedy.

Comments 0

  1. Sheldon L Malone says:
    2 years ago

    My Dr aka the clinic limited my Rx and now to get more oxycodone I have to see a specialist and pay more.
    The pain clinic are reluctant to give me what I think is needed. My next Rx may be my last. Not my choice but it will be my choice.
    Suboxone may be my answer but I will not know until I do the process. The ARNP doesn’t seem to listen and provide alternatives but more oxycodone and it was my idea to try the Suboxone and the DR would have to find their policy and process for the Suboxone. I got the feeling they don’t like using it, maybe it doesn’t work.

    Reply
  2. Jacqueline says:
    2 years ago

    Your efforts are greatly appreciated by the chronic pain community. If more physicians like yourself would have stood against the Guidelines from the start, it could have had an impact. I cannot wrap my head around it. Never in my entire life did I expect to be in this position of not being able to get individualized, patient centered care. As we are well aware, the Guidelines have and continue to cause unecessary harm to innocent patients and physicians. I really don’t know how or if we will ever recover from this. It’s truly shameful and unacceptable. .

    Reply
  3. Monty Goddard says:
    2 years ago

    Not sure how I missed this article for the past five days. It is powerful! I have already archived it and will be posting it on multiple pain forums!

    Reply

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Videos

summary

An in-depth exploration of drug pricing, including key databases like NADAC, WAC, and ASP, and how they influence the pharmaceutical supply chain, policy, and patient advocacy. The episode also introduces MedPricer's innovative pricing intelligence platform, offering valuable insights for healthcare professionals, policymakers, and patients.

Chapters

00:00 Understanding Drug Pricing Dynamics
03:52 Exploring the Drug Pricing Database
10:07 Patient Advocacy and Drug Pricing
13:56 Market Intelligence in Drug Pricing
How NADAC, WAC, and ASP Shape Drug CostsDaily Remedy
YouTube Video X-Tfwy7XKEg
Subscribe

Policy Shift in Peptide Regulation

Clinical Reads

FDA Evaluation of Certain Bulk Drug Substances in Compounding: Clinical Interpretation

FDA Evaluation of Certain Bulk Drug Substances in Compounding: Clinical Interpretation

by Daily Remedy
April 19, 2026
0

Clinicians increasingly encounter patients using or requesting peptide-based therapies sourced through compounding pharmacies. The U.S. Food and Drug Administration has identified a subset of bulk drug substances, including certain peptides, that may present significant safety risks when used in compounded formulations. The clinical question is whether these regulatory signals reflect meaningful patient-level risk and how they should influence prescribing behavior. This matters because compounded peptides often sit outside traditional approval pathways, creating uncertainty around quality, dosing consistency, and safety. Understanding...

Read more

Join Our Newsletter!

Twitter Updates

Tweets by TheDailyRemedy

Popular

  • Drug Pricing Transparency in an Era of Political Polarization: What MedPricer’s Data Reveals About a Contested Policy Landscape

    Drug Pricing Transparency in an Era of Political Polarization: What MedPricer’s Data Reveals About a Contested Policy Landscape

    0 shares
    Share 0 Tweet 0
  • Employer-Sponsored Insurance Is Breaking Down. Price Data Tells You Where It’s Happening First.

    0 shares
    Share 0 Tweet 0
  • The Importance of Access Control in the Workplace

    0 shares
    Share 0 Tweet 0
  • Detecting Hospital M&A Synergies Before They’re Announced: A Rate-Based Event Strategy

    0 shares
    Share 0 Tweet 0
  • State Regulators and the Federal Data Gap: How MedPricer Fills What CMS Leaves Incomplete

    0 shares
    Share 0 Tweet 0
  • 628 Followers

Daily Remedy

Daily Remedy offers the best in healthcare information and healthcare editorial content. We take pride in consistently delivering only the highest quality of insight and analysis to ensure our audience is well-informed about current healthcare topics - beyond the traditional headlines.

Daily Remedy website services, content, and products are for informational purposes only. We do not provide medical advice, diagnosis, or treatment. All rights reserved.

Important Links

  • Support Us
  • About Us
  • Contact us
  • Privacy Policy
  • Terms and Conditions

Join Our Newsletter!

  • Survey
  • Podcast
  • About Us
  • Contact us

© 2026 Daily Remedy

No Result
View All Result
  • Home
  • Articles
  • Podcasts
  • Surveys
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner

© 2026 Daily Remedy